These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1937556)

  • 21. Hydrolytic enzymes as virulence factors of Candida albicans.
    Schaller M; Borelli C; Korting HC; Hube B
    Mycoses; 2005 Nov; 48(6):365-77. PubMed ID: 16262871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils.
    Svobodová E; Staib P; Losse J; Hennicke F; Barz D; Józsi M
    J Immunol; 2012 Sep; 189(5):2502-11. PubMed ID: 22851712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients.
    Antony G; Saralaya V; Gopalkrishna Bhat K; Shalini Shenoy M; Shivananda PG
    Rev Iberoam Micol; 2009 Sep; 26(3):202-5. PubMed ID: 19635443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathomechanisms in Candida albicans infections].
    Ollert M; Korting HC; Braun-Falco O
    Hautarzt; 1988 Aug; 39(8):498-503. PubMed ID: 3065293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination.
    Zakikhany K; Naglik JR; Schmidt-Westhausen A; Holland G; Schaller M; Hube B
    Cell Microbiol; 2007 Dec; 9(12):2938-54. PubMed ID: 17645752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response to Candida albicans cell wall antigens.
    López-Ribot JL; Casanova M; Murgui A; Martínez JP
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):187-96. PubMed ID: 15196567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida albicans and HIV-1 Infection.
    Pugliese A; Torre D; Baccino FM; Di Perri G; Cantamessa C; Gerbaudo L; Saini A; Vidotto V
    Cell Biochem Funct; 2000 Dec; 18(4):235-41. PubMed ID: 11180285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans.
    Hogan DA; Sundstrom P
    Future Microbiol; 2009 Dec; 4(10):1263-70. PubMed ID: 19995187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity.
    Ruiz-Herrera J; Elorza MV; Valentín E; Sentandreu R
    FEMS Yeast Res; 2006 Jan; 6(1):14-29. PubMed ID: 16423067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.
    Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT
    FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Virulence factors of Candida albicans].
    Staniszewska M; Bondaryk M; Piłat J; Siennicka K; Magda U; Kurzatkowski W
    Przegl Epidemiol; 2012; 66(4):629-33. PubMed ID: 23484392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hgc1 mediates dynamic Candida albicans-endothelium adhesion events during circulation.
    Wilson D; Hube B
    Eukaryot Cell; 2010 Feb; 9(2):278-87. PubMed ID: 20023069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between cell surface composition, adherence, and virulence of Candida albicans.
    McCourtie J; Douglas LJ
    Infect Immun; 1984 Jul; 45(1):6-12. PubMed ID: 6376361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces.
    Hostetter MK
    Clin Microbiol Rev; 1994 Jan; 7(1):29-42. PubMed ID: 8118789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-parasite relationships in candidosis.
    Calderone RA
    Mycoses; 1989; 32 Suppl 2():12-7. PubMed ID: 2700215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.
    Hostetter MK
    Diabetes; 1990 Mar; 39(3):271-5. PubMed ID: 2407580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro.
    Gruber A; Lell CP; Speth C; Stoiber H; Lass-Flörl C; Sonneborn A; Ernst JF; Dierich MP; Würzner R
    Immunology; 2001 Dec; 104(4):455-61. PubMed ID: 11899432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia and extraintestinal dissemination of Candida albicans yeast forms.
    Kim AS; Garni RM; Henry-Stanley MJ; Bendel CM; Erlandsen SL; Wells CL
    Shock; 2003 Mar; 19(3):257-62. PubMed ID: 12630526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenicity of "Candida albicans" for normal mice and mice treated by the mycotoxin diacetoxyscirpenol (author's transl)].
    Fromentin H; Salazar-Mejicanos S; Mariat F
    Ann Microbiol (Paris); 1980; 131B(1):39-46. PubMed ID: 7006482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.